Inspire Announces Launch Of DIQUASTM By Santen In Japan
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced that DIQUASTM Ophthalmic Solution 3% (diquafosol tetrasodium) received pricing approval and was launched for sale today in Japan by its partner, Santen Pharmaceutical Co., Ltd. Inspire will receive a related milestone payment of $1...